Brandon Capital Partners

 

About Us

 

The Medical Research Commercialisation Fund (MRCF) was established in 2007 as an innovative investment collaboration. The MRCF invests in early stage development and commercialisation opportunities emanating from Australian medical research institutes and allied research hospitals. The MRCF was founded through collaboration between Australia’s leading medical research institutes and Statewide and Westscheme Superannuation funds, with support from the State Governments of Victoria, New South Wales and Western Australia. The MRCF is an evergreen fund that is managed by Brandon Capital Partners, an experienced life science fund manager.

 The MRCF provides its Members with a range of benefits, including:

  • An early-stage fund dedicated to supporting the development and commercialisation of early-stage medical technologies;
  • Access to risk-tolerant investment capital to support the development of promising technologies, including Proof-of-Principle;
  • Involvement in and exposure to the Investment Review process; and
  • The investors gain access to promising technologies emanating from the Member Institutes.

 
Brandon Capital Partners